Cover Image

Metformin augments GPRC5D in multiple myeloma and enhances the efficacy of GPRC5D‐CAR T cells

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Xiaoli Hu, Xinyi Zhou, Qian Zhao, Ying Yang, Yang Liang, Yuchen Xiao, Zhuoqun Liu, Liu Liu, Chao Zhang, Juan Du
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Retreatment with talquetamab and pomalidomide in triple‐class– BCMA – GPRC5D refractory myeloma
by: Kian J. Rahbari, et al.
Published: (2026)

Reversing the sequence: Efficacy of BCMA‐directed therapy following progression on GPRC5D ‐directed therapies in relapsed multiple myeloma
by: Laura Joiner, et al.
Published: (2025)

Are we there yet? CAR ‐T therapy in multiple myeloma
by: Eitan Mirvis, et al.
Published: (2024)

Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T‐cells
by: Iñaki Ortiz de Landazuri, et al.
Published: (2024)

Dysplastic plasma cells in multiple myeloma
by: Marco P. Barros Pinto
Published: (2025)

Autologous stem cell transplantation for multiple myeloma patients whose myeloma‐defining event was SLiM
by: Iuliana Vaxman, et al.
Published: (2024)

Induction prior to autologous haematopoietic cell transplantation in multiple myeloma
by: Mohamad Mohty, et al.
Published: (2024)

CCR5 predicts neurotoxicity in CAR‐T‐cell therapy
by: Ayal Rozenberg, et al.
Published: (2025)

Atypical mast cells and multiple myeloma: An ambiguous alliance with diagnostic implications
by: Jean‐Baptiste Rieu, et al.
Published: (2026)

Etoposide combined with cytarabine and pegfilgrastim for poorly mobilizing patients with multiple myeloma and lymphoma: A prospective multicentre study
by: Peipei Ye, et al.
Published: (2024)

A rare complication during autologous stem cell transplantation in multiple myeloma
by: Valeria Tomarchio, et al.
Published: (2025)

Preliminary investigation into the association of serum free kappa light chains with risk stratification, clonal evolution and precision therapy in multiple myeloma
by: Chenbo Yang, et al.
Published: (2026)

The role of proliferating stem‐like plasma cells in relapsed or refractory multiple myeloma: Insights from single‐cell RNA sequencing and proteomic analysis
by: Jiadai Xu, et al.
Published: (2024)

Emerging role of G protein‐coupled receptor class C group 5 member D‐directed immunotherapy in multiple myeloma: Advances, resistance and combination strategies
by: Xueting Wang, et al.
Published: (2025)

Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome‐scale CRISPR‐Cas9 screening in myeloma cells
by: Miao Li, et al.
Published: (2024)

Risk of infections with bispecific antibodies in B‐cell non‐Hodgkin lymphomas and multiple myeloma—The current state
by: Amrit S. Gonugunta, et al.
Published: (2024)

Busulfan, melphalan and carfilzomib high‐dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma
by: Patrick Hagen, et al.
Published: (2024)

Outcomes of frail patients undergoing high‐dose chemotherapy and autologous stem cell transplantation for multiple myeloma
by: Stephanie Yohay, et al.
Published: (2024)

CD71+ erythroid cells promote multiple myeloma progression and impair anti‐bacterial immune response
by: K. Czubak, et al.
Published: (2024)

BCL2 inhibition for multiple myeloma and AL amyloidosis
by: Lorenzo Cani, et al.
Published: (2025)

Teclistamab for relapsed refractory multiple myeloma patients on dialysis
by: P. Lebreton, et al.
Published: (2024)

Giant myeloma cells or crystal‐storing histiocytes?
by: Hongwei Chen, et al.
Published: (2026)

Early M‐protein immune reconstitution after autologous haematopoietic stem cell transplantation is a good prognostic marker for patients with high‐risk cytogenetic multiple myeloma
by: Huihui Zhu, et al.
Published: (2024)

The interleukin‐6 connection: Understanding cytomegalovirus reactivation following CAR ‐T‐cell therapy
by: Linghao Li, et al.
Published: (2025)

Treatment‐specific differences in soluble B‐cell maturation antigen levels at minimum residual disease negativity in multiple myeloma
by: Masanori Toho, et al.
Published: (2026)

The CAR T‐cell race: The rules of the game
by: Adriana Balduzzi
Published: (2024)

STAT5 phosphorylation plus minimal residual disease defines a novel risk classification in adult B‐cell acute lymphoblastic leukaemia
by: Xiuli Xu, et al.
Published: (2024)

Incidence and mortality of multiple myeloma: Global, regional and national estimates and projections from the Global Burden of Disease Study 2021
by: Fujun Qu, et al.
Published: (2026)

Inconsistent definitions of transplant ineligibility in multiple myeloma: A systematic review
by: Karun Neupane, et al.
Published: (2026)

Risk‐adapted treatment in multiple myeloma: Does more make it merrier?
by: Saurabh Zanwar, et al.
Published: (2024)

Iberdomide, ixazomib and dexamethasone in elderly patients with multiple myeloma at first relapse
by: Cyrille Touzeau, et al.
Published: (2025)

Coagulation abnormalities associated with CAR‐T‐cell therapy in haematological malignancies: A review
by: Xiaojuan Peng, et al.
Published: (2024)

Multiple myeloma with acicular crystalline inclusion bodies
by: Wei Cai, et al.
Published: (2024)

Success of donor‐derived CAR‐T cells after failure of autologous CD19 CAR‐T cells (tisagenlecleucel) in B‐cell acute lymphoblastic leukaemia
by: Marie Emilie Dourthe, et al.
Published: (2024)

T‐cell‐based immunotherapies for human immunodeficiency virus patient with relapsed/refractory multiple myeloma: A success story from our clinic
by: S. Moraru, et al.
Published: (2025)

Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma
by: M. R. Seefat, et al.
Published: (2025)

Dutcher bodies and Russell bodies in a case of t(11;14) multiple myeloma
by: Jing Wu, et al.
Published: (2024)

Preferred standard‐of‐care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologists
by: Rahul Banerjee, et al.
Published: (2026)

Early detection of multiple myeloma: A first step towards a screening programme
by: Christof Scheid, et al.
Published: (2024)

First relapse in older adults with multiple myeloma: Creating new pathways in uncharted territory
by: Tanya M. Wildes
Published: (2025)